Zane was just 15 months old when his parents noticed something wasn’t right. His eyes, legs and belly were very swollen. At first, it seemed like allergies. As soon as the pediatrician saw Zane, he ...

Spontaneous remission rarely occurs in patients with primary FSGS. Patients with primary FSGS and massive proteinuria are also unlikely to respond to angiotensin II blockade with reduction of ...

There is no cure for focal segmental glomerulosclerosis (FSGS), but the proper care can keep your kidneys healthy for years. FSGS treatment that includes an early diagnosis, personalized treatment, ...

Focal segmental glomerulosclerosis (FSGS) is a rare kidney disorder that affects children and adults, and can lead to kidney failure. New findings from a team led by the University of Minnesota ...

Eric M. Dube, President and CEO, described Q2 2025 as "a standout for Travere, a reflection of strong strategic execution and continued momentum in delivering against our mission." He highlighted ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Treatment for 72.1% of patients involved in-center ...

CEO Eric Dube reported strong progress for the quarter, highlighting FILSPARI's foundational role in treating IgA nephropathy (IgAN). Net sales of FILSPARI increased 13% sequentially and 182% ...

If approved, FILSPARI would be the first and only FDA-approved treatment for FSGS, a rare kidney condition and a leading cause of kidney failure SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. ...